Sign In
Buy DGX
$196.12
+2.45 (+1.27%)
At Close: Jun 04, 2026
These 3 Companies Are Taking on Monkeypox
02:37pm, Thursday, 04'th Aug 2022 The Motley Fool
A vaccine maker, a therapeutics company, and a medical lab could suit a variety of investor risk profiles.
Tandem Diabetes (TNDM) Q2 Earnings Miss, Sales View Cut
12:40pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Factoring the pandemic and competitive pressure as well as the evolving economic environment, including inflation and the threat of recession, Tandem Diabetes (TNDM) cuts its full-year guidance.
These 3 Companies Are Taking on Monkeypox
10:37am, Thursday, 04'th Aug 2022
A vaccine maker, a therapeutics company, and a medical lab could suit a variety of investor risk profiles.
CVS Health (CVS) Q2 Earnings Beat Estimates, Margins Down
04:30pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
CVS Health (CVS) posts better-than-expected results in Q2, with robust performances across all operating segments driving the top line.
Exact Sciences (EXAS) Q2 Earnings Top Estimates, Margins Down
04:17pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Exact Sciences (EXAS) posts better-than-expected earnings and revenues in Q2 with robust performances across the Screening and Precision Oncology segments.
Charles River (CRL) Q2 Earnings Top Estimates, 2022 View Cut
02:27pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Revenue decline in the CDMO business drag Charles River's (CRL) Manufacturing Solutions revenues down.
STERIS (STE) Q1 Earnings Match Estimates, EPS View Down
01:54pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
STERIS' (STE) revenues at AST improve driven by increased demand from medical device and biopharma customers.
Henry Schein (HSIC) Q2 Earnings Top Estimates, '22 EPS View Up
04:14pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Henry Schein (HSIC) reports better-than-expected Q2 earnings with impressive sales growth across the Medical and Technology and Value-added Services segments.
DaVita (DVA) Beats on Q2 Earnings, Reiterates FY22 EPS View
03:39pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
DaVita (DVA) records an overall solid Q2 performance owing to strength in its Other segment's revenues and uptick in total U.S. dialysis treatments.
Zimmer Biomet (ZBH) Q2 Earnings Top Estimates, 2022 View Up
02:36pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
The contraction in Zimmer Biomet's (ZBH) gross margin is concerning.
IDEXX (IDXX) Q2 Earnings Surpass Estimates, 2022 View Down
02:25pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
IDEXX's (IDXX) Q2 top-line benefits from strong sales at the CAG and Water businesses.
Avantor's (AVTR) Stock Falls 8.8% Since Q2 Earnings Miss
07:05am, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Avantor's (AVTR) robust performance across majority of its segments drives its Q2 sales, despite business challenges.
Teleflex's (TFX) Q2 Earnings Top Estimates, 2022 View Down
01:47pm, Monday, 01'st Aug 2022 Zacks Investment Research
For UroLift, Teleflex (TFX) witnesses revenue declines in all sites of service, including hospital, ASC and physician's office.
Chemed (CHE) Q2 Earnings Surpass Estimates, Margins Grow
05:57pm, Friday, 29'th Jul 2022 Zacks Investment Research
Chemed (CHE) reports better-than-expected earnings in the second quarter, with a robust performance by the Roto-Rooter segment driving the top line.
Edwards Lifesciences (EW) Q2 Earnings Meet Estimates, Margins Up
05:54pm, Friday, 29'th Jul 2022 Zacks Investment Research
Edwards Lifesciences (EW) posts Q2 earnings in line with the Zacks Consensus Estimate, with robust performances across all product groups driving the top line.
